Crystal Adam: insider trades.
Crystal Adam reported 8 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 5 sales ($2.1M), across 1 company.
- Transactions
- 8
- Purchases (P)
- 0
- Sales (S)
- 5
- Companies
- 1
- Name as filed
- Crystal Adam
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Tango Therapeutics, Inc. (TNGX) | Officer · President, R&D | 8 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-01 | Tango Therapeutics, Inc. | S | 27,000 | $22.37 | 115,743 | Form 4 |
| 2026-09-01 | Tango Therapeutics, Inc. | M | 27,000 | $5.2 | 142,743 | Form 4 |
| 2026-08-03 | Tango Therapeutics, Inc. | S | 21,733 | $27.35 | 115,743 | Form 4 |
| 2026-08-03 | Tango Therapeutics, Inc. | S | 5,267 | $26.79 | 137,476 | Form 4 |
| 2026-08-03 | Tango Therapeutics, Inc. | M | 27,000 | $5.2 | 142,743 | Form 4 |
| 2026-07-01 | Tango Therapeutics, Inc. | M | 27,000 | $5.2 | 142,743 | Form 4 |
| 2026-07-01 | Tango Therapeutics, Inc. | S | 7,371 | $30.25 | 115,743 | Form 4 |
| 2026-07-01 | Tango Therapeutics, Inc. | S | 19,629 | $29.34 | 123,114 | Form 4 |
Questions
What stock did Crystal Adam buy or sell?
Crystal Adam reported 8 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 5 sales ($2.1M), across 1 company.
Is Crystal Adam the same person as other filers with this name?
This page covers SEC CIK 1825445 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/crystal-adam-1825445.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.